Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
Conditions
- Heart Failure of Reduced Ejection Fraction (HFrEF)
Interventions
- DRUG: Jardiance
- DRUG: non-SGLT2 inhibitors
Sponsor
Boehringer Ingelheim